Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dexter

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Journal of Neuroendocrinology|April 3, 2016
Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier ModelD Gonzalez-Carter, A E Goode, R Fiammengo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 20, 2020
Iron and inflammation: in vivo and post-mortem studies in Parkinson's diseaseAntonio Martin-Bastida, Bension Shlomo Tilley, Sukhi Bansal, et al.
Cell Death & Disease|June 15, 2013
Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signallingM G Thomas, M Saldanha, R J Mistry, et al.
Journal of the American College of Nutrition|October 2, 2007
Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's diseaseKrishna P Datla, Virginia Zbarsky, Deepal Rai, et al.
Journal of Consulting and Clinical Psychology|December 3, 2008
Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by expertsMelanie S Harned, Alexander L Chapman, Elizabeth T Dexter-Mazza, et al.
Journal of Neurochemistry|June 1, 1989
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseD T Dexter, F R Wells, A J Lees, et al.
Neurogenetics|December 14, 2005
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's diseaseL B Moran, D C Duke, M Deprez, et al.
Journal of Neuroimmunology|April 14, 2012
Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expressionM Sadeghian, L Marinova-Mutafchieva, L Broom, et al.
Lancet (London, England)|November 21, 1987
Increased nigral iron content in postmortem parkinsonian brainD T Dexter, F R Wells, F Agid, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 30, 2010
Iron and the immune systemRoberta J Ward, Robert R Crichton, Deanna L Taylor, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Journal of Neuroendocrinology|April 3, 2016
Inhibition of Leptin-ObR Interaction Does not Prevent Leptin Translocation Across a Human Blood-Brain Barrier ModelD Gonzalez-Carter, A E Goode, R Fiammengo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 20, 2020
Iron and inflammation: in vivo and post-mortem studies in Parkinson's diseaseAntonio Martin-Bastida, Bension Shlomo Tilley, Sukhi Bansal, et al.
Cell Death & Disease|June 15, 2013
Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signallingM G Thomas, M Saldanha, R J Mistry, et al.
Journal of the American College of Nutrition|October 2, 2007
Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's diseaseKrishna P Datla, Virginia Zbarsky, Deepal Rai, et al.
Journal of Consulting and Clinical Psychology|December 3, 2008
Treating co-occurring Axis I disorders in recurrently suicidal women with borderline personality disorder: a 2-year randomized trial of dialectical behavior therapy versus community treatment by expertsMelanie S Harned, Alexander L Chapman, Elizabeth T Dexter-Mazza, et al.
Journal of Neurochemistry|June 1, 1989
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's diseaseD T Dexter, F R Wells, A J Lees, et al.
Neurogenetics|December 14, 2005
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's diseaseL B Moran, D C Duke, M Deprez, et al.
Journal of Neuroimmunology|April 14, 2012
Full and partial peroxisome proliferation-activated receptor-γ agonists, but not δ agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expressionM Sadeghian, L Marinova-Mutafchieva, L Broom, et al.
Lancet (London, England)|November 21, 1987
Increased nigral iron content in postmortem parkinsonian brainD T Dexter, F R Wells, F Agid, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 30, 2010
Iron and the immune systemRoberta J Ward, Robert R Crichton, Deanna L Taylor, et al.
Pageof 14